South East Sydney and Illawarra Area Health Service Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01231139
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Dr. M.K. Saxena | South East Sydney Illawarra Area Health Service

Active Ingredients

Drugs in Phase 2 Trials (2)

acetaminophen (tylenol) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 2)

Brain Injuries, Traumatic (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2